Bausch Health Companies Inc (BHC) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $6.04
• Market Cap: $2.27B
• P/E Ratio: 14.55
• EPS: $0.42
• 52-Week High: $8.69
• 52-Week Low: $4.25

Market Sentiment

Bausch Health Companies Inc currently has a Bullish sentiment score of 0.18.

About Bausch Health Companies Inc

Bausch Health Companies Inc. (BHC) is a prominent global player in the development, manufacturing, and marketing of a broad range of pharmaceutical, medical device, and over-the-counter (OTC) products, emphasizing specialties such as eye health, gastroenterology, and dermatology. Based in Laval, Canada, the company utilizes its diverse portfolio to meet significant medical needs and improve patients' quality of life globally. Bausch Health's strategic focus on innovation and growth fosters a ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Bausch Health Companies Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BHC pay dividends?

Bausch Health Companies Inc (BHC) does not currently pay a regular dividend.

What is BHC's P/E ratio?

Bausch Health Companies Inc has a price-to-earnings (P/E) ratio of 14.55.

What is BHC's market cap?

Bausch Health Companies Inc (BHC) has a market capitalization of $2.27B with a current stock price of $6.04.